180 related articles for article (PubMed ID: 34035221)
1. OTUD7B stabilizes estrogen receptor α and promotes breast cancer cell proliferation.
Tang J; Wu Z; Tian Z; Chen W; Wu G
Cell Death Dis; 2021 May; 12(6):534. PubMed ID: 34035221
[TBL] [Abstract][Full Text] [Related]
2. MINDY1 promotes breast cancer cell proliferation by stabilizing estrogen receptor α.
Tang J; Luo Y; Long G; Zhou L
Cell Death Dis; 2021 Oct; 12(10):937. PubMed ID: 34645792
[TBL] [Abstract][Full Text] [Related]
3. USP35, regulated by estrogen and AKT, promotes breast tumorigenesis by stabilizing and enhancing transcriptional activity of estrogen receptor α.
Cao J; Wu D; Wu G; Wang Y; Ren T; Wang Y; Lv Y; Sun W; Wang J; Qian C; He L; Yang K; Li H; Gu H
Cell Death Dis; 2021 Jun; 12(6):619. PubMed ID: 34131114
[TBL] [Abstract][Full Text] [Related]
4. Stabilization of estrogen receptor α by USP37 contributes to the progression of breast cancer.
Cao J; Wang X; Wang S; Chen Z; Tang J
Cancer Sci; 2023 May; 114(5):2041-2052. PubMed ID: 36221793
[TBL] [Abstract][Full Text] [Related]
5. Deubiquitination and stabilization of estrogen receptor α by ubiquitin-specific protease 7 promotes breast tumorigenesis.
Xia X; Liao Y; Huang C; Liu Y; He J; Shao Z; Jiang L; Dou QP; Liu J; Huang H
Cancer Lett; 2019 Nov; 465():118-128. PubMed ID: 31518603
[TBL] [Abstract][Full Text] [Related]
6. The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor α and modulates estrogen-stimulated breast cancer cell proliferation.
Zhu J; Zhao C; Kharman-Biz A; Zhuang T; Jonsson P; Liang N; Williams C; Lin CY; Qiao Y; Zendehdel K; Strömblad S; Treuter E; Dahlman-Wright K
Oncogene; 2014 Aug; 33(34):4340-51. PubMed ID: 24441041
[TBL] [Abstract][Full Text] [Related]
7. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
[TBL] [Abstract][Full Text] [Related]
8. TRIM11 promotes breast cancer cell proliferation by stabilizing estrogen receptor α.
Tang J; Luo Y; Tian Z; Liao X; Cui Q; Yang Q; Wu G
Neoplasia; 2020 Sep; 22(9):343-351. PubMed ID: 32599554
[TBL] [Abstract][Full Text] [Related]
9. An H3K4me3 reader, BAP18 as an adaptor of COMPASS-like core subunits co-activates ERα action and associates with the sensitivity of antiestrogen in breast cancer.
Sun G; Wang C; Wang S; Sun H; Zeng K; Zou R; Lin L; Liu W; Sun N; Song H; Liu W; Zhou T; Jin F; Shan Z; Zhao Y
Nucleic Acids Res; 2020 Nov; 48(19):10768-10784. PubMed ID: 32986841
[TBL] [Abstract][Full Text] [Related]
10. The ubiquitin ligase RNF181 stabilizes ERα and modulates breast cancer progression.
Zhu J; Li X; Su P; Xue M; Zang Y; Ding Y
Oncogene; 2020 Oct; 39(44):6776-6788. PubMed ID: 32973333
[TBL] [Abstract][Full Text] [Related]
11. PFKFB3 regulates breast cancer tumorigenesis and Fulvestrant sensitivity by affecting ERα stability.
Jia W; Wu Q; Shen M; Yu X; An S; Zhao L; Huang G; Liu J
Cell Signal; 2024 Jul; 119():111184. PubMed ID: 38640982
[TBL] [Abstract][Full Text] [Related]
12. ASXL2 promotes proliferation of breast cancer cells by linking ERα to histone methylation.
Park UH; Kang MR; Kim EJ; Kwon YS; Hur W; Yoon SK; Song BJ; Park JH; Hwang JT; Jeong JC; Um SJ
Oncogene; 2016 Jul; 35(28):3742-52. PubMed ID: 26640146
[TBL] [Abstract][Full Text] [Related]
13. RNF8 identified as a co-activator of estrogen receptor α promotes cell growth in breast cancer.
Wang S; Luo H; Wang C; Sun H; Sun G; Sun N; Zeng K; Song H; Zou R; Zhou T; Cong R; Liu W; Yang L; Li D; Zhou X; Zhong X; Lin L; Jiao J; Yan G; Wang X; Min X; Cao L; Zhao Y
Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1615-1628. PubMed ID: 28216286
[TBL] [Abstract][Full Text] [Related]
14. MiR-301a-3p Suppresses Estrogen Signaling by Directly Inhibiting ESR1 in ERα Positive Breast Cancer.
Lettlova S; Brynychova V; Blecha J; Vrana D; Vondrusova M; Soucek P; Truksa J
Cell Physiol Biochem; 2018; 46(6):2601-2615. PubMed ID: 29763890
[TBL] [Abstract][Full Text] [Related]
15. OTUD7B Deubiquitinates LSD1 to Govern Its Binding Partner Specificity, Homeostasis, and Breast Cancer Metastasis.
Gong Z; Li A; Ding J; Li Q; Zhang L; Li Y; Meng Z; Chen F; Huang J; Zhou D; Hu R; Ye J; Liu W; You H
Adv Sci (Weinh); 2021 Aug; 8(15):e2004504. PubMed ID: 34050636
[TBL] [Abstract][Full Text] [Related]
16. The GPER1/SPOP axis mediates ubiquitination-dependent degradation of ERα to inhibit the growth of breast cancer induced by oestrogen.
Zhang N; Sun P; Xu Y; Li H; Liu H; Wang L; Cao Y; Zhou K; TinghuaiWang
Cancer Lett; 2021 Feb; 498():54-69. PubMed ID: 33069770
[TBL] [Abstract][Full Text] [Related]
17. CUEDC1 is a primary target of ERα essential for the growth of breast cancer cells.
Lopes R; Korkmaz G; Revilla SA; van Vliet R; Nagel R; Custers L; Kim Y; van Breugel PC; Zwart W; Moumbeini B; Manber Z; Elkon R; Agami R
Cancer Lett; 2018 Nov; 436():87-95. PubMed ID: 30145202
[TBL] [Abstract][Full Text] [Related]
18. Fulvestrant inhibits growth of triple negative breast cancer and synergizes with tamoxifen in ERα positive breast cancer by up-regulation of ERβ.
Mishra AK; Abrahamsson A; Dabrosin C
Oncotarget; 2016 Aug; 7(35):56876-56888. PubMed ID: 27486755
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor (ER)α-regulated lipocalin 2 expression in adipose tissue links obesity with breast cancer progression.
Drew BG; Hamidi H; Zhou Z; Villanueva CJ; Krum SA; Calkin AC; Parks BW; Ribas V; Kalajian NY; Phun J; Daraei P; Christofk HR; Hewitt SC; Korach KS; Tontonoz P; Lusis AJ; Slamon DJ; Hurvitz SA; Hevener AL
J Biol Chem; 2015 Feb; 290(9):5566-81. PubMed ID: 25468909
[TBL] [Abstract][Full Text] [Related]
20. The deubiquitinating enzyme USP15 stabilizes ERα and promotes breast cancer progression.
Xia X; Huang C; Liao Y; Liu Y; He J; Shao Z; Hu T; Yu C; Jiang L; Liu J; Huang H
Cell Death Dis; 2021 Mar; 12(4):329. PubMed ID: 33771975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
